Mass spectrometry – a century-old technique that ionises a sample to measure the combined masses of its atoms – has established itself as a tool to test food and environmental contamination, perform carbon dating, confirm drug abuse and tackle a host of other tasks.
Biological applications of mass spectrometry in particular have grown exponentially since the discovery of ‘soft’ ionisation techniques over 20 years ago, which has since allowed researchers to analyse much bigger molecules than was ever possible before. Combined with huge leaps in computational power, today the detailed interrogation of viruses, antibodies or proteins from cells in human and other animals in mass spectrometers is routine.
With the ability to identify, characterise and quantify proteins and other molecules present in a particular network, pathway, organelle, subcellular complex, cell or tissue – and even measure post-translational modifications – state-of-the-art mass spectrometric methods have become an essential part of any researcher’s repertoire who is interested in understanding the nature and interactions of molecules in an organism.
Seeding a functional proteomics revolution
Yet despite significant progress, the ultimate goal of being able to monitor and analyse what is happening at the molecular level in every type of cell at every time – called functional proteomics – remains elusive. This is because functional proteomics is orders of magnitude more difficult than DNA sequencing, and today’s mass spectrometers fall far short of what is needed in terms of sensitivity, dynamic range and speed.
The ‘Biological Mass Spectrometry’ theme aims to seed a functional proteomics revolution by bringing together the UK’s world-leading technology companies and strong but currently disparate academic expertise in mass spectrometry.
The Science Directors of the theme, Professor Josephine Bunch and Professor Zoltan Takats, are consulting their communities on proposals for technologies to be developed in the mass spectrometry theme.
A key objective of the Biological Mass Spectrometry theme is to construct a unique multimodal imaging mass spectrometer instrument, which allows the molecular mapping of biological tissues at unprecedented sensitivity, chemical depth and spatial resolution. The instrument is envisioned to not only detect the building blocks of tissues, but also provide proper structural characterisation of all detected molecular species and supramolecular complexes.
Mass spectrometric imaging is a unique tool providing spatially resolved chemical information, which is particularly important for structural biology and molecular histology research. The currently available MSI approaches target different classes of molecular species at different spatial resolution and analytical sensitivity. While all of these techniques detect thousands of unknown molecular constituents, currently there is no integrated solution for their proper identification/structural elucidation.
The proposed instrument will provide comprehensive chemical information ranging from inorganic ions to multimeric supramolecular complexes at subcellular spatial resolution and will enable the swift structural identification of all species detected. The team believe that such an instrument at the crossroads of physical sciences, engineering, life sciences and biomedical research gives a perfect fit to the Franklin’s objectives.
The BMS theme, together with the other themes focusing on structural chemistry & biology, will bring along a new understanding on the compartmentalisation of molecular interaction networks. This new knowledge will stem from the untargeted co-localisation of an unprecedentedly broad range of biochemically relevant species in tissues and it will equally serve the fundamental understanding of cellular biology, pathobiochemistry and the development of new and innovative therapeutic approaches for various disease ranging from infectious diseases through dementia to cancer. Being the construction of a unique platform, this project has the potential to define the Franklin as worldwide hub for structural biochemistry.
To be added to the mailing list for Biological Mass spectrometry and receive theme related updates, please e-mail firstname.lastname@example.org.
Professor Josephine Bunch
Science Co-Director, Biological Mass Spectrometry
Professor Josephine Bunch is Co-Director of the National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI) at NPL and Chair […]
Professor Zoltan Takats
Science Co-Director, Biological Mass Spectrometry
Professor Takats has obtained his PhD from Eötvös Loránd University, Budapest, Hungary. He has worked as a post-doctoral research associate […]
Microscope mode MSI
This instrument will allow for ultrafast, high throughput mass spectrometry imaging. Unlike standard probe-based sampling approaches, this offers vast improvements in imaging throughput. This novel...Project details
High resolution MSI
A novel Secondary Ion Mass Spectrometry (SIMS) instrument will be constructed to include a water cluster ion source and laser post-ionisation. Gas cluster and water...Project details
Hybrid Imaging Instrument
This Hybrid Imaging instrument aims to make it possible for high-mass resolution measurements to be conducted in a spatially resolved manner. The instrument combines a...Project details